Associated Genetic Biomarkers
Associated Diseases

Overview

Location [1]
10q24.32
Protein [2]
Nuclear factor NF-kappa-B p52 subunit
Synonyms [1]
LYT-10, LYT10, p100, p52, NF-kB2, H2TF1, CVID10, p49/p100

Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) (NFKB2) is a gene that encodes a protein that functions as a subunit of the transcription factor complex nuclear factor-kappa-B. The protein activates genes that participate in inflammation and immunity. Fusions, missense mutations, nonsense mutations, silent mutations, frameshift deletions, and in-frame deletions are observed in cancers such as bone cancer, endometrial cancer, and skin cancer.

NFKB2 is altered in 0.98% of all cancers.

The most common alterations in NFKB2 are NFKB2 Mutation (0.02%), NFKB2 P430S (0.00%), NFKB2 D617Y (0.00%), NFKB2 D94E (0.00%), and NFKB2 G359D (0.00%) [3].

NFKB2 GENIE Cases - Top Alterations

Significance of NFKB2 in Diseases

Multiple Myeloma +

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.